"Today's Top Stock Movers: Cytokinetics, 4D Molecular Therapeutics, and Beyond"

Stock futures were lower on Monday as U.S. Federal Reserve Chair Jerome Powell's comments tempered expectations for near-term interest rate cuts. Biggest gainers included Catalent accepting an acquisition proposal from Novo Holdings, Estee Lauder's soaring shares following better than expected FQ2 results and a "Profit Recovery Plan," Nvidia's rise after Goldman Sachs reiterated its Conviction Buy rating, 4D Molecular Therapeutics' shares jumping on positive interim data from a clinical trial, and Elanco's stock increasing after Merck's agreement to acquire its aqua business. On the other hand, Air Products and Chemicals saw a 15% drop due to disappointing earnings, while Cytokinetics and NanoString Technologies also experienced declines.